These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3179168)

  • 1. Theophylline-terbutaline, a steady state study on possible pharmacokinetic interactions with special reference to chronopharmacokinetic aspects.
    Jonkman JH; Borgström L; van der Boon WJ; de Noord OE
    Br J Clin Pharmacol; 1988 Sep; 26(3):285-93. PubMed ID: 3179168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of bambuterol in healthy subjects.
    Nyberg L; Rosenborg J; Weibull E; Jönsson S; Kennedy BM; Nilsson M
    Br J Clin Pharmacol; 1998 May; 45(5):471-8. PubMed ID: 9643620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of terbutaline given in slow-release tablets.
    Nyberg L; Kennedy BM
    Eur J Respir Dis Suppl; 1984; 134():119-39. PubMed ID: 6586473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased theophylline clearance in asthmatic patients due to terbutaline.
    Garty M; Paul-Keslin L; Ilfeld DN; Mazar A; Spitzer S; Rosenfeld JB
    Eur J Clin Pharmacol; 1989; 36(1):25-8. PubMed ID: 2917584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels.
    Billing B; Dahlqvist R; Garle M; Hörnblad Y; Ripe E
    Eur J Respir Dis; 1982 Sep; 63(5):399-409. PubMed ID: 7140872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous treatment with terbutaline and theophylline.
    Billing B; Dahlqvist R; Garle M; Hörnblad Y; Ripe E
    Eur J Respir Dis Suppl; 1984; 134():211-8. PubMed ID: 6586482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronopharmacokinetics of theophylline in the cat.
    Dye JA; McKiernan BC; Neff-Davis CA; Koritz GD
    J Vet Pharmacol Ther; 1990 Sep; 13(3):278-86. PubMed ID: 2231868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No pharmacokinetic or pharmacodynamic interaction between theophylline and the leukotriene biosynthesis inhibitor BAY x 1005.
    Groen H; Moesker HL; Leeuwenkamp OR; Sollie FA; Jonkman JH
    J Clin Pharmacol; 1996 Jul; 36(7):639-46. PubMed ID: 8844447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of short-term subcutaneous terbutaline on theophylline disposition.
    Snidow J; Stephens M; Self T; Stewart C; Bobo L; Pieper JA
    Eur J Clin Pharmacol; 1987; 32(2):191-3. PubMed ID: 3582484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between theophylline and enoxacin.
    Takagi K; Hasegawa T; Yamaki K; Suzuki R; Watanabe T; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):288-92. PubMed ID: 3165968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic parameters of terbutaline in healthy man. An overview.
    Nyberg L
    Eur J Respir Dis Suppl; 1984; 134():149-60. PubMed ID: 6586475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the enantiomers of terbutaline after repeated oral dosing with racemic terbutaline.
    Borgström L; Liu CX; Walhagen A
    Chirality; 1989; 1(2):174-7. PubMed ID: 2642046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
    Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha-interferon on theophylline pharmacokinetics and metabolism.
    Jonkman JH; Nicholson KG; Farrow PR; Eckert M; Grasmeijer G; Oosterhuis B; De Noord OE; Guentert TW
    Br J Clin Pharmacol; 1989 Jun; 27(6):795-802. PubMed ID: 2757895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man.
    Wittenbrink-Dix AM; Neugebauer G; Fuhr U; Neubert P; Besenfelder E; Woelke-Seidl E; Harder S; Staib AH
    Arzneimittelforschung; 1989 Oct; 39(10A):1339-43. PubMed ID: 2576359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.